Glioma, Malignant

Explore clinical trials studying Glioma, Malignant. Study availability and eligibility vary by location and protocol.

47 public trials 19 recruiting studies

Refine in advanced search Browse all conditions

Glioma, Malignant trial results

Active, Not Recruiting

Niraparib In Recurrent IDH 1/2 Gliomas

NCT05406700

Conditions: Glioma, Glioma, Malignant, IDH1 Mutation, +10 more
Locations: Massachusetts General Hospital Boston, Massachusetts, United States

View Trial Details

Active, Not Recruiting

ETAPA I: Peptide-based Tumor Associated Antigen Vaccine in GBM

NCT05283109

Conditions: Astrocytoma, Glioblastoma, Glioma, +8 more
Locations: The Preston Robert Tisch Brain Tumor Center at Duke University Durham, North Carolina, United States

View Trial Details

Active, Not Recruiting

AZD1390 in Recurrent and Newly Diagnosed WHO Grade 4 Glioma Patients

NCT05182905

Conditions: Astrocytoma, Glioblastoma, Glioblastoma Multiforme, +9 more
Locations: St. Joseph's Hospital and Medical Center Phoenix, Arizona, United States

View Trial Details

Active, Not Recruiting

Trial of Niraparib in Participants With Newly-diagnosed Glioblastoma and Recurrent Glioma

NCT05076513

Conditions: Astrocytoma, GBM, Glioblastoma, +11 more
Locations: St. Joseph's Hospital and Medical Center Phoenix, Arizona, United States

View Trial Details

Active, Not Recruiting

An Integrated Radio-immunological Approach

NCT05267509

Conditions: Glioma, Glioma, Malignant, Neoplasms, +6 more
Locations: University Hospital Florence, Italy

University Hospital Padova, Italy

View Trial Details

Active, Not Recruiting

Radiomics-Based Visualization and Quantitative Validation of IDH1 Heterogeneity in Gliomas

NCT05969691

Conditions: Computer-Assisted, Glioma, Glioma, Malignant, +7 more
Locations: Huashan Hospital, Fudan University Shanghai, Shanghai Municipality, China

View Trial Details

Active, Not Recruiting

Intraoperative Rapid Diagnosis of Glioma Based on Fusion of Magnetic Resonance and Ultrasound Imaging

NCT05656053

Conditions: Computer-assisted Surgery, Glioma, Glioma, Malignant, +7 more
Locations: Fudan University Shanghai, Shanghai Municipality, China

View Trial Details

Glioma, Malignant

Glioma, Malignant trial results

Niraparib In Recurrent IDH 1/2 Gliomas

ETAPA I: Peptide-based Tumor Associated Antigen Vaccine in GBM

AZD1390 in Recurrent and Newly Diagnosed WHO Grade 4 Glioma Patients

Trial of Niraparib in Participants With Newly-diagnosed Glioblastoma and Recurrent Glioma

An Integrated Radio-immunological Approach

Radiomics-Based Visualization and Quantitative Validation of IDH1 Heterogeneity in Gliomas

Intraoperative Rapid Diagnosis of Glioma Based on Fusion of Magnetic Resonance and Ultrasound Imaging

Related conditions